EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Blautia coccoides -derived acetate potentiates anti-PD-1 immunotherapy in melanoma by activating cytotoxic CD8 + T cells

Zhiwen Zhang, Xiaofeng Liang, Yuyang Tian, Chengyi Li, Xueli Cao, Di Wang, Ansheng Xie, Siqi Liu, Kefan Lin, Qing Li, Yunsheng Liang

Journal for ImmunoTherapy of Cancer · 2026-07 · 14 (7) · e015617

DOI: 10.1136/jitc-2026-015617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 16.07.2026. Verfasst von Zhiwen Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Key Laboratory of Medical Epigenomics & Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, Ch…. Hauptthemen laut MEDLINE: Acetates, Immunotherapy, Immune Checkpoint Inhibitors, CD8-Positive T-Lymphocytes. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Guangdong Basic and Applied Basic Research Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gut microbiota can modulate cancer immunotherapy and enhance the efficacy of programmed cell death protein 1 (PD-1) blockade in tumors, yet the responsible microbes and underlying mechanisms remain incompletely understood.

Methods

Publicly available anti-PD-1-treated melanoma microbiome cohorts were reanalyzed. Causal validation was performed using oral Blautia coccoides ( B. coccoides ) supplementation in B16-F10 melanoma-bearing mice. Untargeted and targeted liquid chromatography-tandem mass spectrometry-based metabolomics, CD8 + T-cell depletion, receptor identification and binding analyses, and downstream transcriptomic and biochemical assays were used to identify the key metabolite and investigate its mechanism of action.

Results

We identified Blautia as enriched in melanoma patients responding to immune checkpoint inhibitors, with higher abundance associated with non-progression. In melanoma-bearing mice, oral B. coccoides suppressed tumor growth and increased intratumoral effector CD8 + T cells. Metabolomic profiling identified acetate as a prominent B. coccoides -associated metabolite. Acetate enhanced CD8 + T-cell effector function. CD8 + T-cell depletion largely abrogated the antitumor effects of both B. coccoides and acetate, supporting a central role for CD8 + T cells. Mechanistically, these findings support a model in which acetate is associated with a TLR3-linked signaling pathway in CD8 + T cells, accompanied by PI3K/Akt activation and enhanced effector function. Notably, B. coccoides or acetate potentiated anti-PD-1 therapy in mouse melanoma models, supporting their potential as adjunctive strategies for melanoma immunotherapy.

Conclusions

These findings support a model of an acetate-TLR3-linked PI3K/Akt signaling axis linking microbiota-associated metabolites to CD8 + T cell-mediated antitumor immunity. Importantly, our study highlights both B. coccoides and its derivative, acetate, as preclinical adjunctive candidates to potentiate anti-PD-1 efficacy in melanoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetatesImmunotherapyImmune Checkpoint InhibitorsCD8-Positive T-LymphocytesMelanoma, ExperimentalMelanomaProgrammed Cell Death 1 ReceptorT-Lymphocytes, CytotoxicAnimalsMiceHumansMice, Inbred C57BLFemale

Stichwörter der Autor:innen

Immune Checkpoint InhibitorImmunotherapyMelanomaT-LymphocytesToll-like receptor - TLR

Substanzen

AcetatesImmune Checkpoint InhibitorsProgrammed Cell Death 1 Receptor

Autor:innen und Institutionen

  • Hunan Key Laboratory of Medical Epigenomics & Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • The First School of Clinical Medicine, Southern Medical University; Department of Dermatology, Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, China.
  • The First School of Clinical Medicine, Southern Medical University; Department of Dermatology, Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, China yunshengliang@aliyun.com drliqing@smu.edu.cn.
  • Hunan Key Laboratory of Medical Epigenomics & Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China yunshengliang@aliyun.com drliqing@smu.edu.cn.

Förderung

  • Guangdong Basic and Applied Basic Research Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Z., Liang, X., Tian, Y., Li, C., Cao, X., Wang, D., Xie, A., Liu, S., Lin, K., Li, Q., & Liang, Y. (2026). Blautia coccoides -derived acetate potentiates anti-PD-1 immunotherapy in melanoma by activating cytotoxic CD8 + T cells. Journal for ImmunoTherapy of Cancer, 14(7), e015617. https://doi.org/10.1136/jitc-2026-015617

Vancouver

Zhang Z, Liang X, Tian Y, Li C, Cao X, Wang D, et al. Blautia coccoides -derived acetate potentiates anti-PD-1 immunotherapy in melanoma by activating cytotoxic CD8 + T cells. Journal for ImmunoTherapy of Cancer. 2026;14(7):e015617. doi:10.1136/jitc-2026-015617

BibTeX
@article{Zhang2026,
  author = {Zhang, Zhiwen and Liang, Xiaofeng and Tian, Yuyang and Li, Chengyi and Cao, Xueli and Wang, Di and Xie, Ansheng and Liu, Siqi and Lin, Kefan and Li, Qing and Liang, Yunsheng},
  title = {Blautia coccoides -derived acetate potentiates anti-PD-1 immunotherapy in melanoma by activating cytotoxic CD8 + T cells},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  volume = {14},
  number = {7},
  pages = {e015617},
  doi = {10.1136/jitc-2026-015617}
}
Kostenlos starten →